Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 57.00 | |
2 mg | In stock | $ 83.00 | |
5 mg | In stock | $ 143.00 | |
10 mg | In stock | $ 226.00 | |
25 mg | In stock | $ 383.00 | |
50 mg | In stock | $ 569.00 | |
100 mg | In stock | $ 816.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 162.00 |
Description | NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM) |
In vivo | From haemodynamic assessments, NTP42 reduced the MCT-induced PAH, including mean pulmonary arterial pressure (mPAP) and right systolic ventricular pressure (RSVP), being at least comparable to the standard-of-care drugs Sildenafil or Selexipag in bringing about these effects.?Moreover, NTP42 was superior to Sildenafil and Selexipag in significantly reducing pulmonary vascular remodelling, inflammatory mast cell infiltration and fibrosis in MCT-treated animals[1]. |
Molecular Weight | 515.53 |
Formula | C25H23F2N3O5S |
CAS No. | 2055599-51-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (58.19 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NTP42 2055599-51-2 DNA Damage/DNA Repair GPCR/G Protein Immunology/Inflammation Metabolism Prostaglandin Receptor PPAR pulmonary Inhibitor inhibit PAH NTP-42 hypertension TXA2 thromboxane arterial NTP 42 inhibitor